139 related articles for article (PubMed ID: 27538915)
1. Rifampin-Mediated Induction of Tamoxifen Metabolism in a Humanized PXR-CAR-CYP3A4/3A7-CYP2D6 Mouse Model.
Chang JH; Chen J; Liu L; Messick K; Ly J
Drug Metab Dispos; 2016 Nov; 44(11):1736-1741. PubMed ID: 27538915
[TBL] [Abstract][Full Text] [Related]
2. Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells.
Sane RS; Buckley DJ; Buckley AR; Nallani SC; Desai PB
Drug Metab Dispos; 2008 May; 36(5):946-54. PubMed ID: 18299335
[TBL] [Abstract][Full Text] [Related]
3. Modulation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation by ursolic acid (UA) attenuates rifampin-isoniazid cytotoxicity.
Chang HY; Chen CJ; Ma WC; Cheng WK; Lin YN; Lee YR; Chen JJ; Lim YP
Phytomedicine; 2017 Dec; 36():37-49. PubMed ID: 29157826
[TBL] [Abstract][Full Text] [Related]
4. Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 Transgenic Mouse Models To Assess the Magnitude of CYP3A4 Mediated Drug-Drug Interactions.
Ly JQ; Messick K; Qin A; Takahashi RH; Choo EF
Mol Pharm; 2017 May; 14(5):1754-1759. PubMed ID: 28345929
[TBL] [Abstract][Full Text] [Related]
5. Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction.
Ly JQ; Wong S; Liu L; Li R; Messick K; Chang JH
Drug Metab Dispos; 2021 Jul; 49(7):540-547. PubMed ID: 33863817
[TBL] [Abstract][Full Text] [Related]
6. Differences in Gene Regulation by Dual Ligands of Nuclear Receptors Constitutive Androstane Receptor (CAR) and Pregnane X Receptor (PXR) in HepG2 Cells Stably Expressing CAR/PXR.
Kanno Y; Tanuma N; Yazawa S; Zhao S; Inaba M; Nakamura S; Nemoto K; Inouye Y
Drug Metab Dispos; 2016 Aug; 44(8):1158-63. PubMed ID: 27197997
[TBL] [Abstract][Full Text] [Related]
7. A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.
Ma X; Cheung C; Krausz KW; Shah YM; Wang T; Idle JR; Gonzalez FJ
Drug Metab Dispos; 2008 Dec; 36(12):2506-12. PubMed ID: 18799805
[TBL] [Abstract][Full Text] [Related]
8. Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor.
Choo EF; Woolsey S; DeMent K; Ly J; Messick K; Qin A; Takahashi R
Drug Metab Dispos; 2015 Jun; 43(6):864-9. PubMed ID: 25813936
[TBL] [Abstract][Full Text] [Related]
9. Fucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells.
Liu CL; Lim YP; Hu ML
Mar Drugs; 2012 Jan; 10(1):242-257. PubMed ID: 22363234
[TBL] [Abstract][Full Text] [Related]
10. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
Gupta A; Mugundu GM; Desai PB; Thummel KE; Unadkat JD
Drug Metab Dispos; 2008 Jun; 36(6):1172-80. PubMed ID: 18332086
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice.
Felmlee MA; Lon HK; Gonzalez FJ; Yu AM
Drug Metab Dispos; 2008 Feb; 36(2):435-41. PubMed ID: 18048490
[TBL] [Abstract][Full Text] [Related]
12. Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver.
Hasegawa M; Tahara H; Inoue R; Kakuni M; Tateno C; Ushiki J
Drug Metab Dispos; 2012 Mar; 40(3):474-80. PubMed ID: 22126990
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.
Desai PB; Nallani SC; Sane RS; Moore LB; Goodwin BJ; Buckley DJ; Buckley AR
Drug Metab Dispos; 2002 May; 30(5):608-12. PubMed ID: 11950795
[TBL] [Abstract][Full Text] [Related]
14. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
15. Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammation.
Kittayaruksakul S; Zhao W; Xu M; Ren S; Lu J; Wang J; Downes M; Evans RM; Venkataramanan R; Chatsudthipong V; Xie W
Pharm Res; 2013 Sep; 30(9):2199-208. PubMed ID: 23896737
[TBL] [Abstract][Full Text] [Related]
16. Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes.
Kandel BA; Thomas M; Winter S; Damm G; Seehofer D; Burk O; Schwab M; Zanger UM
Biochim Biophys Acta; 2016 Sep; 1859(9):1218-1227. PubMed ID: 26994748
[TBL] [Abstract][Full Text] [Related]
17. Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes.
Roth A; Looser R; Kaufmann M; Meyer UA
Pharmacogenet Genomics; 2008 Apr; 18(4):325-37. PubMed ID: 18334917
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes.
Haines C; Elcombe BM; Chatham LR; Vardy A; Higgins LG; Elcombe CR; Lake BG
Toxicology; 2018 Mar; 396-397():23-32. PubMed ID: 29425889
[TBL] [Abstract][Full Text] [Related]
19. Oleanolic Acid-Mediated Inhibition of Pregnane X Receptor and Constitutive Androstane Receptor Attenuates Rifampin-Isoniazid Cytotoxicity.
Lin YN; Chen CJ; Chang HY; Cheng WK; Lee YR; Chen JJ; Lim YP
J Agric Food Chem; 2017 Oct; 65(39):8606-8616. PubMed ID: 28945086
[TBL] [Abstract][Full Text] [Related]
20. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients.
Ximenez JPB; de Andrade JM; Marques MP; Coelho EB; Suarez-Kurtz G; Lanchote VL
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):81. PubMed ID: 31852530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]